Foreign-Born Women in U.S. Less Likely to Have Mammograms
Findings remain even after adjusting for common sociodemographic factors.
Breast Cancer
CDK4/6 Inhibitor + AI Therapy is Effective in Both Older and Younger Women With Breast Cancer
Rates of grade 3/4 AEs and dose reductions/interruptions associated with CDK4/6 + AI therapy were higher in those 75 years and older compared with younger patients.
Breast Cancer (Recurrent or Metastatic) Treatment Regimens
Get the latest breast cancer treatment regimens with in-depth drug information on therapies such as tamoxifen, trastuzumab, and docetaxel.
Breast Cancer Mortality Rate Continues to Decline in the US
Pace of decline slowed from 1.9 percent during 1998 to 2011 to 1.3 percent during 2011 to 2017.
Implant-Associated Cancers: A Look Beyond BIA-ALCL
Recent and upcoming case reports suggest possible cases of gluteal and other implant-associated ALCLs, raising questions about the cancer risk across all types of implants.
Efficacy of IV Ferric Carboxymalotose Similar to Traditional Treatments for Prevention of Chemotherapy-Induced Anemia
Using a subset from the GeparOcto trial, researchers sought to determine if IV FCM was superior to physicians’ choice in treating chemotherapy-induced anemia in patients with breast cancer.
Single-Center Study Confirms Scalp Cooling System Can Mitigate Chemotherapy-Induced Alopecia in Women With Breast Cancer
A single-institution study is able to reproduce results of previous studies on the use of a scalp cooling system to prevent chemotherapy-induced hair loss in patients with breast cancer receiving anthracycline and/or taxane-based therapies.
Early Stage Still Important Prognostic Indicator in Nonmetastatic Male Breast Cancer
A meta-analysis of 222 men with nonmetastatic male breast cancer confirmed that disease stage at diagnosis remains an important prognostic factor.
Patient-Specific Survivorship Programs Improve Quality of Life for Patients With Recurrent Breast Cancer
Patient-specific, individualized coaching was found to provide needed support for patients with recurrent breast cancer.
Reading, Literacy Levels of Chemotherapy Educational Materials for Women With Breast Cancer Are Not Optimal
An evaluation of patient education materials on chemotherapy for breast cancer revealed that many do not meet NIH recommendations.
Next post in Breast Cancer
